The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of histologic tumor response on survival of patients treated with neoadjuvant mFOLFOX6 plus bevacizumab for the synchronous liver metastases from colorectal cancer.
Yu Katayose
No relevant relationships to disclose
Kazuyuki Ishida
No relevant relationships to disclose
Kei Nakagawa
No relevant relationships to disclose
Junichiro Yamauchi
No relevant relationships to disclose
Masaya Oikawa
No relevant relationships to disclose
Naoki Sakurai
No relevant relationships to disclose
Hiroaki Musha
No relevant relationships to disclose
Hiromune Shimamura
No relevant relationships to disclose
Koh Miura
No relevant relationships to disclose
Fuyuhiko Motoi
No relevant relationships to disclose
Shinichi Egawa
No relevant relationships to disclose
Michiaki Unno
No relevant relationships to disclose